Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The injectable medicine, sold and patented by Eli Lilly and Company, contains the active ingredient tirzepatide, which was first approved under the brand name Mounjaro in May 2022 to improve glycemic control in people with Type 2 diabetes
Remove it from the refrigerator about 15-30 minutes before injection
Have a private Telehealth consultation with a board-certified Clinician who will determine if medication is a safe and appropriate choice for you
This review study highlights the biological effects of different NAD+ boosters as well as the unique benefits of direct NAD+ administration over oral precursors because it bypasses gut and liver metabolism
The FDA approved a further step to 2 mg weekly in March 2022 for patients who require more intensive A1C lowering 2
